Zoeken | Pikumil

Ates Karahan toegevoegd een audio Other
2026-07-30 06:27:26 -

Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market Opportunity Analysis Report
"According to the latest report published by Data Bridge Market Research, the Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period The winning Dual GIP/ GLP-1 Receptor Agonists...

0 Reacties 0 aandelen 266 Views 0 voorbeeld

Please log in to like, share and comment!
Aishwarya Chavan toegevoegd een audio Religion
2025-11-20 14:51:30 -

Therapeutic Radiopharmaceuticals MarketPotential: Size, Share, Trends, and Future Outlook
"Future of Executive Summary GLP-1 Analogues Market: Size and Share Dynamics The global GLP-1 analogues market size was valued at USD 32.19 billion in 2024 and is expected to reach USD 346.06 billion by 2032, at a CAGR of 34.56% during the forecast period To thrive in this rapidly transforming marketplace, today’s businesses call for innovative and...

0 Reacties 0 aandelen 794 Views 0 voorbeeld

Please log in to like, share and comment!
Rina Choudhary toegevoegd een audio Other
2026-06-17 15:33:53 -

Diabetes Treatments Market Size, Share, and Growth Forecast to 2030
According to the latest report published by Data Bridge Market Research, the Diabetes Treatments Market Data Bridge Market Research analyses that the global diabetes treatments market which was USD 5,370.2 million in 2022, would rocket up to USD 8,920.9 million by 2030, and is expected to undergo a CAGR of 6.5 % during the forecast period. Type-1 segment dominates the type segment of...

0 Reacties 0 aandelen 6K Views 0 voorbeeld

Please log in to like, share and comment!
Priti Jain toegevoegd een audio Other
2026-10-09 05:29:02 -

GLP-1 Market: Research Advancements and Industry Developments
The GLP-1 Market is expanding as therapeutic applications move beyond diabetes into obesity and cardiovascular disease. Valued at USD 52.82 billion in 2025, the GLP-1 Market is projected to reach USD 58.48 billion in 2026 and USD 133.92 billion by 2034, growing at a CAGR of 10.9% during the forecast period 2026–2034. Key players include AstraZeneca, Boehringer Ingelheim, D&D...

0 Reacties 0 aandelen 81 Views 0 voorbeeld

Please log in to like, share and comment!